Page last updated: 2024-11-03

pyrimethamine and Papilledema

pyrimethamine has been researched along with Papilledema in 2 studies

Maloprim: contains above 2 cpds

Papilledema: Swelling of the OPTIC DISK, usually in association with increased intracranial pressure, characterized by hyperemia, blurring of the disk margins, microhemorrhages, blind spot enlargement, and engorgement of retinal veins. Chronic papilledema may cause OPTIC ATROPHY and visual loss. (Miller et al., Clinical Neuro-Ophthalmology, 4th ed, p175)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mikhail, MA1
Varikkara, M1
Dralands, L1

Other Studies

2 other studies available for pyrimethamine and Papilledema

ArticleYear
The absence of vitreous inflammation: one more challenge in diagnosing toxoplasma papillitis.
    BMJ case reports, 2013, Apr-09, Volume: 2013

    Topics: Adolescent; Anti-Bacterial Agents; Antiprotozoal Agents; Azithromycin; Diagnosis, Differential; Drug

2013
[Harmful effects of common drugs on the visual apparatus. Anti-infective drugs. D. Antiprotozoal agents].
    Bulletin de la Societe belge d'ophtalmologie, 1972, Volume: 160, Issue:1

    Topics: Amidines; Antiprotozoal Agents; Blindness; Eye Diseases; Humans; Metronidazole; Papilledema; Photose

1972